Cargando…
Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084395/ https://www.ncbi.nlm.nih.gov/pubmed/30101001 http://dx.doi.org/10.18632/oncotarget.25791 |
_version_ | 1783346170264813568 |
---|---|
author | Reeves, Patrick M. Abbaslou, Mojgan A. Kools, Farah R.W. Vutipongsatorn, Kritchai Tong, Xiaoyun Gavegnano, Christina Schinazi, Raymond F. Poznansky, Mark C. |
author_facet | Reeves, Patrick M. Abbaslou, Mojgan A. Kools, Farah R.W. Vutipongsatorn, Kritchai Tong, Xiaoyun Gavegnano, Christina Schinazi, Raymond F. Poznansky, Mark C. |
author_sort | Reeves, Patrick M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6084395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-60843952018-08-10 Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice Reeves, Patrick M. Abbaslou, Mojgan A. Kools, Farah R.W. Vutipongsatorn, Kritchai Tong, Xiaoyun Gavegnano, Christina Schinazi, Raymond F. Poznansky, Mark C. Oncotarget Correction Impact Journals LLC 2018-07-13 /pmc/articles/PMC6084395/ /pubmed/30101001 http://dx.doi.org/10.18632/oncotarget.25791 Text en Copyright: © 2018 Reeves et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Reeves, Patrick M. Abbaslou, Mojgan A. Kools, Farah R.W. Vutipongsatorn, Kritchai Tong, Xiaoyun Gavegnano, Christina Schinazi, Raymond F. Poznansky, Mark C. Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice |
title | Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice |
title_full | Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice |
title_fullStr | Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice |
title_full_unstemmed | Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice |
title_short | Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice |
title_sort | correction: ruxolitinib sensitizes ovarian cancer to reduced dose taxol, limits tumor growth and improves survival in immune competent mice |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084395/ https://www.ncbi.nlm.nih.gov/pubmed/30101001 http://dx.doi.org/10.18632/oncotarget.25791 |
work_keys_str_mv | AT reevespatrickm correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice AT abbasloumojgana correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice AT koolsfarahrw correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice AT vutipongsatornkritchai correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice AT tongxiaoyun correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice AT gavegnanochristina correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice AT schinaziraymondf correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice AT poznanskymarkc correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice |